Learn about the Latest Therapy Approved by the FDA for Gastroesophageal Cancer Patients
A new type of therapy has been approved by the FDA for patients with Gastroesophageal Adenocarcinoma. Learn more. On [...]
A new type of therapy has been approved by the FDA for patients with Gastroesophageal Adenocarcinoma. Learn more. On [...]
Needed Biomarker Testing Not Happening for Patients with Advanced Gastroesophageal Cancer in Many Community Practices. In a Project with [...]
The Food and Drug Administration (FDA) has approved Zolbetuximab (Vyloy) as a first-line treatment for patients with advanced HER2* [...]
A German study finds a 30% reduction in the risk of death among Esophageal Adenocarcinoma patients who were treated [...]
In 2021, Esophageal Cancer patients and advocates celebrated the Food and Drug Administration’s approval of immunotherapies for patients with [...]
A newly released study of the benefits of the EsoGuard® Esophageal DNA test says it is a powerful screening [...]
At the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, long-term data from [...]
A breakthrough by researchers at Case Western Reserve has led to the discovery of an Inherited Gene Mutation linked to [...]
With animations that illustrate how to prevent, detect, treat, and cure Esophageal Cancer, ECAN, in partnership with the International Society [...]
ECAN is proud to launch a new, personalized service to match Esophageal Cancer patients with the best Clinical Trial [...]